tirzepatide patent challenge Mounjaro expiration: Drug patents expiring in 2036 Lilly releases Zepbound® (tirzepatide) single-dose

Conducted by Eli Lilly, these trials involved over 2,000 adults and showcased an average of up to 28.3% body weight loss at higher dosages

RAND researchers surveyed participants of the RAND American Life Panel to ask about use of GLP-1 drugs and their experiences with side effects

Ongoing nausea may reduce food and fluid intake, increasing the likelihood of dehydration, which can create conditions that favour kidney stone formation

Pull back the plunger to draw in air equal to your prescribed dose

J Diabetes Investig 1(12):823 Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G et al (2019) Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus

However, more research is needed to establish its effectiveness in these areas